Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and creatine phosphate sodium in patients undergoing intracranial hematoma evacuation or cardiopulmonary bypass surgery
ChiCTR-IPR-14005656Phase 4Not yet recruiting
- Sponsor
- Southern District of Anhui Provincial Hospital
- Start
- Dec 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and phosphocreatine in intracerebral hemorrhage (ICH) and cardiac disease (3 arms), sponsored by Southern District of Anhui Provincial Hospital. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 3 more. Planned start Dec 2014; status: not yet recruiting.
02
Drugs
dexmedetomidinephosphocreatine
03
Conditions
intracerebral hemorrhage (ICH)cardiac disease
Beyond the preview
Go deeper on ChiCTR-IPR-14005656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005656.